Open Access

Expression level of TBX3 gene in renal carcinoma and its clinical significance

  • Authors:
    • Yifan Wang
  • View Affiliations

  • Published online on: January 22, 2018     https://doi.org/10.3892/ol.2018.7841
  • Pages: 4235-4240
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The aim of the current study was to investigate and discuss the function of T-box 3 (TBX3) gene expression in the pathogenesis of renal carcinoma. The carcinoma, adjacent and normal renal tissues of 210 patients with renal carcinoma who presented to The Central Hospital of Wuhan, Tongji Medical College from March, 2006 to March, 2012 were collected to extract total RNAs. The total RNAs were reverse‑transcribed into complementary DNA (cDNA), and quantitative polymerase chain reaction (qPCR) was applied to detect the expression of TBX3 gene in these tissues, followed by its association with the prognosis of renal carcinoma as well as clinical features. A comparison of the renal carcinoma tissues with the adjacent tissues showed that TBX3 gene was obviously highly expressed in renal carcinoma tissues (P<0.05). In addition, compared with normal renal tissues, TBX3 gene was obviously highly expressed in renal carcinoma tissues (P<0.05). There was no significant difference in the expression levels of TBX3 gene in normal renal tissues and adjacent tissues (P=0.15). The expression of TBX3 gene in renal carcinoma tissues was not associated with patient age, sex and tumor size (P>0.05), but it was associated with tumor-node-metastasis (TNM) staging and lymph node metastasis (P<0.05). The Kaplan-Meier survival analysis revealed that the median survival time of patients in the positive TBX3 gene expression group (37.5 months) was shorter than that in the negative TBX3 gene expression group (66 months), and there was a statistical difference (P<0.05). The 3- and 5-year survival rates in the negative TBX3 gene expression group were 74 and 62%, respectively, and the 3- and 5-year survival rates in the positive TBX3 gene expression group were 52 and 32%, respectively, and the differences were significant (P<0.05). The results suggest that TBX3 gene is highly expressed in renal carcinoma tissues, and it is associated with TNM staging, lymph node metastasis and distant metastasis, which may be involved in the occurrence and metastasis of renal carcinoma.

References

1 

Fang Y, Bao W, Rao Q, Wang X, Xia Q, Shen Q, Zhou X and Yao B: TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway. Mol Med Rep. 16:2721–2725. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI

3 

Russo P: Renal cell carcinoma: Presentation, staging, and surgical treatment. Semin Oncol. 27:160–176. 2000.PubMed/NCBI

4 

Papaioannou VE: The T-box gene family: Emerging roles in development, stem cells and cancer. Development. 141:3819–3833. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Ito A, Asamoto M, Hokaiwado N, Takahashi S and Shirai T: Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells. Cancer Lett. 219:105–112. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Ansari D, Rosendahl A, Elebro J and Andersson R: Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. Br J Surg. 98:1041–1055. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Boyd SC, Mijatov B, Pupo GM, Tran SL, Gowrishankar K, Shaw HM, Goding CR, Scolyer RA, Mann GJ, Kefford RF, et al: Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion. J Invest Dermatol. 133:1269–1277. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Liu J, Esmailpour T, Shang X, Gulsen G, Liu A and Huang T: TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model. BMC Dev Biol. 11:652011. View Article : Google Scholar : PubMed/NCBI

9 

Lu R, Yang A and Jin Y: Dual functions of T-box 3 (Tbx3) in the control of self-renewal and extra embryonic endoderm differentiation in mouse embryonic stem cells. J Biol Chem. 286:8425–8436. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Dhawan P, Singh AB, Ellis DL and Richmond A: Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res. 62:7335–7342. 2002.PubMed/NCBI

11 

Renard CA, Labalette C, Armengol C, Cougot D, Wei Y, Cairo S, Pineau P, Neuveut C, de Reynies A, Dejean A, et al: Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Cancer Res. 67:901–910. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Yarosh W, Barrientos T, Esmailpour T, Lin L, Carpenter PM, Osann K, Anton-Culver H and Huang T: TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res. 68:693–699. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Wang HC, Meng QC, Shan ZZ, Yuan Z and Huang XY: Overexpression of Tbx3 predicts poor prognosis of patients with resectable pancreatic carcinoma. Asian Pac J Cancer Prev. 16:1397–1401. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Shan ZZ, Yan XB, Yan LL, Tian Y, Meng QC, Qiu WW, Zhang Z and Jin ZM: Overexpression of Tbx3 is correlated with epithelial-mesenchymal transition phenotype and predicts poor prognosis of colorectal cancer. Am J Cancer Res. 5:344–353. 2015.PubMed/NCBI

15 

Redmond KL, Crawford NT, Farmer H, D'Costa ZC, O'Brien GJ, Buckley NE, Kennedy RD, Johnston PG, Harkin DP and Mullan PB: T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells. Oncogene. 29:3252–3262. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Shen J, Lu J, Sui L, Wang D, Yin M, Hoffmann I, Legler A and Pflugfelder GO: The orthologous Tbx transcription factors Omb and TBX2 induce epithelial cell migration and extrusion in vivo without involvement of matrix metalloproteinases. Oncotarget. 5:11998–12015. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Fischer K and Pflugfelder GO: Putative breast cancer driver mutations in TBX3 cause impaired transcriptional repression. Front Oncol. 5:2442015. View Article : Google Scholar : PubMed/NCBI

18 

Smith J, Mowla S and Prince S: Basal transcription of the human TBX3 gene, a key developmental regulator which is overexpressed in several cancers, requires functional NF-Y and Sp1 sites. Gene. 486:41–46. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Capparelli C, Chiavarina B, Whitaker-Menezes D, Pestell TG, Pestell RG, Hulit J, Andò S, Howell A, Martinez-Outschoorn UE, Sotgia F, et al: CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, ‘fueling’ tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle. 11:3599–3610. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Li Y, Li B, Xu B, Han B, Xia H, Chen QM and Li LJ: Expression of p53, p21(CIP1/WAF1) and eIF4E in the adjacent tissues of oral squamous cell carcinoma: Establishing the molecular boundary and a cancer progression model. Int J Oral Sci. 7:161–168. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Varelas X, Bouchie MP and Kukuruzinska MA: Protein N-glycosylation in oral cancer: Dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling. Glycobiology. 24:579–591. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Li J, Weinberg MS, Zerbini L and Prince S: The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway. Mol Biol Cell. 24:3569–3576. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, et al: Colon Cancer Family Registry and the Genetics and Epidemiology of Colorectal Cancer Consortium: Identification of genetic susceptibility loci for colorectal tumors in a Genome-Wide meta-analysis. Gastroenterology. 144:799–807.e24. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Peres J, Davis E, Mowla S, Bennett DC, Li JA, Wansleben S and Prince S: The highly homologous T-Box transcription factors, TBX2 and TBX3, have distinct roles in the oncogenic process. Genes Cancer. 1:272–282. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Li J, Ballim D, Rodriguez M, Cui R, Goding CR, Teng H and Prince S: The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3. J Biol Chem. 289:35633–35643. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Walker AS, Johnson EK, Maykel JA, Stojadinovic A, Nissan A, Brucher B, Champagne BJ and Steele SR: Future directions for the early detection of colorectal cancer recurrence. J Cancer. 5:272–280. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Wang HC, Meng QC, Shan ZZ, Yuan Z and Huang XY: Overexpression of Tbx3 predicts poor prognosis of patients with resectable pancreatic carcinoma. Asian Pac J Cancer Prev. 16:1397–1401. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Shan ZZ, Yan XB, Yan LL, Tian Y, Meng QC, Qiu WW, Zhang Z and Jin ZM: Overexpression of Tbx3 is correlated with Epithelial-Mesenchymal Transition phenotype and predicts poor prognosis of colorectal cancer. Am J Cancer Res. 5:344–353. 2014.PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, Y. (2018). Expression level of TBX3 gene in renal carcinoma and its clinical significance. Oncology Letters, 15, 4235-4240. https://doi.org/10.3892/ol.2018.7841
MLA
Wang, Y."Expression level of TBX3 gene in renal carcinoma and its clinical significance". Oncology Letters 15.4 (2018): 4235-4240.
Chicago
Wang, Y."Expression level of TBX3 gene in renal carcinoma and its clinical significance". Oncology Letters 15, no. 4 (2018): 4235-4240. https://doi.org/10.3892/ol.2018.7841